Funding Alert
Ratan Tata-backed Generic Aadhaar receives funding from Japanese firm Beyond Next Ventures
-
ByStartupStory | August 1, 2022
Generic Aadhaar, a pharmaceutical startup has received an undisclosed investment in its current Pre-Series A fundraising round from Japanese venture capital firm Beyond Next Ventures. The startup’s post-money valuation after this round is Rs 500 Cr.
The additional funding would be used by Generic Aadhaar to increase the number of its franchise stores in India to 3000. The startup will also make investments in expanding its product line and its digitization strategy.
Arjun Deshpande, founder and CEO of Generic Aadhaar said, “The funds, whose deployment we want to complete over the next eight months, will enable us to expand more quickly and have a bigger effect by addressing the problem of drug shortages in urban, Tier-2, and Tier-3 areas across India. We want to complete Series-A financing in the next 8 to 12 months after receiving an incredible reaction from our clients.”
Deshpande founded Generic Aadhaar at the age of sixteen to offer generic medications that are up to 80% less expensive than branded medications now on the market. Additionally, generic medications can be sold on the market without middlemen or additional research. The firm offers up to 40% profit to shop owners by selling its items directly to customers through franchise-owned stores.
About Generic Aadhaar
Deshpande founded the Mumbai-based firm in 2018, which distributes generic medications through a network of franchisees. Franchise operators can also use the programme for inventory and billing. Competition in the pharmaceutical sector comes from companies like Truemeds and Dava India.
Also Read
-
-
Clean-label food brand Anveshan has raised Rs 150 crore (nearly $16 million) in a Series B funding round led by Vertex Ventures Southeast Asia & India. The round also saw participation from International Finance Corporation (IFC), Swiggy co-founder Sri Harsha Majety, and existing investors including Wipro Consumer Care Ventures, Titan Capital Winners Fund, Force Ventures, and boAt co-founders Aman Gupta and Sameer Mehta. Entrackr had exclusively reported the development last week. According to Entrackr’s estimates, the funding valued the company at over $90 million. The fresh capital will be used to strengthen manufacturing capabilities, accelerate product development, expand offline distribution, and deepen its digital presence. The company also plans to invest in sourcing infrastructure, procurement systems, quality assurance, and testing capabilities while expanding partnerships with micro entrepreneurs and traditional producers. Founded in 2020 by Kuldeep Parewa, Akhil Kansal, and Aayushi Khandelwal, Anveshan sells minimally processed food products including A2 bilona ghee, cold-pressed oils, raw honey, atta, and other traditional nutrition-focused products. The startup operates through a network of rural producers and micro entrepreneurs across the country. Anveshan claims to be operating at an annual revenue run rate of Rs 280-300 crore and is targeting Rs 1,000 crore in revenue over the next 24-30 months. The company plans to expand its atta portfolio, strengthen its owned digital channels, scale offline distribution, and continue investing in product innovation. For the fiscal year ended March 2025, Anveshan reported a 64.6% increase in operating revenue to Rs 77.08 crore from Rs 46.84 crore in FY24. Its losses widened to Rs 11.88 crore in FY25 from Rs 5.74 crore in the previous fiscal year....
Follow Startup Story
